Literature DB >> 22151749

Focal therapy for localised prostate cancer: are we asking the correct research questions?

Declan G Murphy1, Thomas J Walton, Stephen Connolly, Anthony J Costello.   

Abstract

The goals of focal therapy are laudable, namely reducing morbidity of treatment while ensuring at least equivalent oncological outcomes when compared with established interventions for localised prostate cancer, e.g. RP and external beam radiotherapy. While progress has been made towards better identifying the index lesion in these patients, there is much yet to be done to establish the validity of the index lesion theory as the metastatic focus and to establish that current targeting and ablative platforms are adequate to deliver the goals outlined above. The correct research questions have not yet been asked to establish either of these key principles underpinning focal therapy for localised prostate cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22151749     DOI: 10.1111/j.1464-410X.2011.10804.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

1.  8q24 risk alleles and prostate cancer in African-Barbadian men.

Authors:  Cheryl D Cropp; Christiane M Robbins; Xin Sheng; Anselm J M Hennis; John D Carpten; Lyndon Waterman; Ronald Worrell; Tae-Hwi Schwantes-An; Jeffrey M Trent; Christopher A Haiman; M Cristina Leske; Suh-Yuh Wu; Joan E Bailey-Wilson; Barbara Nemesure
Journal:  Prostate       Date:  2014-09-22       Impact factor: 4.104

Review 2.  Defining the level of evidence for technology adoption in the localized prostate cancer pathway.

Authors:  Massimo Valerio; Ahmed El-Shater Bosaily; Mark Emberton; Hashim U Ahmed
Journal:  Urol Oncol       Date:  2013-12-12       Impact factor: 3.498

Review 3.  Focal therapy for prostate cancer: the technical challenges.

Authors:  Annette Haworth; Scott Williams
Journal:  J Contemp Brachytherapy       Date:  2017-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.